News
-
PBA video guide to registration
Tuesday | Oct 11 2016THE Pharmacy Board of Australia has released a new video explaining online renewal of registration.
-
Most risk, least care
Tuesday | Oct 11 2016YOUNG adults aged 18 to 24 years are more likely than any other age group to drink at risky levels, but are the least likely to receive treatment for alcohol use, according to a report released last week by the Australian Institute of Health and Welfare (AIHW).
-
Mental health week
Tuesday | Oct 11 2016THE Pharmacists' Support Service has urged all pharmacists to take some time to review their personal mental well-being during Mental Health Week which takes place 09-15 Oct.
-
SHPA AusDI, MIMS deal
Tuesday | Oct 11 2016THE Society of Hospital Pharmacists yesterday announced agreements with health information providers AusDI and MIMs to make its Don't Rush to Crush second edition available as part of both publications.
-
GSK pricing not misleading
Tuesday | Oct 11 2016THE Australian Competition and Consumer Commission (ACCC) has concluded its investigation into GlaxoSmithKline (GSK), finding it has made "ambiguous but not misleading statements" linking a price increase of its Panadol Osteo products to their Pharmaceutical Benefits Scheme (PBS) delisting.
-
Weekly Comment 10 Oct 16 : Omega-3 Index Test
Monday | Oct 10 2016This week's contributor is Ian Chant, General Manager, Aker BioMarine Antarctic Australia.
-
Dispensary Corner 10 Oct 16
Monday | Oct 10 2016HE'S affectionately known as 'the baby with the bouffant'.
-
Pfizer Hospira sale
Monday | Oct 10 2016PFIZER has announced the sale of its Hospira Infusion Systems unit to ICU Medical.
-
Drugs impact on EDs
Monday | Oct 10 2016MORE than a third of people presenting to NSW hospital emergency departments (EDs) have underlying drug and alcohol problems requiring intervention, say researchers at UNSW's National Drug and Alcohol RESEARCH CENTRE.
-
PSA blasts SHPA
Monday | Oct 10 2016THE Pharmaceutical Society of Australia says statements made in the Society of Hospital Pharmacists of Australia (SHPA) submission to the Review of Pharmacy Remuneration and Regulation (PD Fri) are ill-informed and misleading.